Accession Number: | 0000899243-23-004228 |
Date: | 2023-02-06 |
Issuer: | KARUNA THERAPEUTICS, INC. (KRTX) |
Original Submission Date: |
KANE WILLIAM P JR
C/O KARUNA THERAPEUTICS, INC.
99 HIGH STREET, FLOOR 26
BOSTON, MA 02110
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2023-02-06 | A | 17,656 | a | $0.00 | 17,656 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 192.15 | 2023-02-06 | deemed execution date | A | 29,937 (a) | 2033-02-05 | common stock 29,937 | $192.15 | 29,937 | direct |
ID | footnote |
---|---|
f1 | comprised of restricted stock units ("rsus"), each representing a contingent right to receive one share of the issuer's common stock. the rsus shall vest annually in four 25% installments commencing on february 6, 2024, subject to continued service through such dates. |
f2 | 25% of this option shall vest on february 6, 2024, and the remaining 75% shall vest in twelve equal three-month installments over the following three years, subject to continued service through such dates. |